Summary:
12-24 week Schizophrenia outpatient Phase 3 study in Schizophrenia subjects on chronic stable antipsychotic therapy.
Qualified Participants Must:
• Be between 18 and 50 years of age
•
Be on antipsychotic therapy
•
Have reliable informant.
Qualified Participants May Receive:
Study related medical care, and compensation for time and travel.